Jones Clare A, Vial Catherine, Sellers Lynda A, Humphrey Pat P A, Evans Richard J, Chessell Iain P
Glaxo Institute of Applied Pharmacology, Cambridge, United Kingdom.
Mol Pharmacol. 2004 Apr;65(4):979-85. doi: 10.1124/mol.65.4.979.
Investigation of rat recombinant P2X(6) receptors has been limited because of the difficulty in obtaining functional expression in heterologous systems. In this study, we demonstrate glycosylation-dependent regulation of recombinant P2X(6) receptor function and associated conferral of a novel phenotype that is sensitive to the P2X(1) and P2X(3) receptor agonist, alphabeta-methylene ATP. In cells functionally expressing P2X(6) receptors, ATP and alphabeta-methylene ATP evoked slowly desensitizing inward currents (EC(50) values, 0.5 and 0.6 microM, respectively) with slow kinetics of current decay on agonist washout. 2',3'-O-(2,4,6-trinitrophenyl ATP) and iso-pyridoxalphosphate-6-azophenyl-2'-5'-disulfonate were effective antagonists (IC(50) values, 0.8 and 22 microM, respectively); however, suramin was relatively ineffective. Reverse transcription-polymerase chain reaction analysis confirmed the absence of other P2X receptor subunits. Western analysis of membrane fractions from functional and nonfunctional clones confirmed the presence of P2X(6) at the cell membrane but revealed a difference in apparent molecular mass of immunoreactive products ( approximately 70 and approximately 60 kDa, respectively). N-glycosidase F treatment of both functional and nonfunctional receptor cell membranes increased the electrophoretic mobilities of immunoreactive products, with both proteins migrating at approximately 55 kDa, demonstrating an increased level of glycosylation of the P2X(6) receptor in functional compared with nonfunctional cells. This study demonstrates that nonfunctional rat recombinant P2X(6) receptors 1) are expressed on the membrane surface of human embryonic kidney cells and 2) are glycosylated. Expression of the novel functional receptor phenotype is associated with further glycosylation, resulting in an apparently larger molecular mass. These results suggest that P2X(6) receptor subunits contribute to alphabeta-methylene ATP sensitivity.
由于在异源系统中难以实现功能性表达,对大鼠重组P2X(6)受体的研究受到限制。在本研究中,我们证明了重组P2X(6)受体功能的糖基化依赖性调节以及对P2X(1)和P2X(3)受体激动剂αβ-亚甲基ATP敏感的新表型的赋予。在功能性表达P2X(6)受体的细胞中,ATP和αβ-亚甲基ATP诱发缓慢脱敏的内向电流(EC(50)值分别为0.5和0.6 microM),激动剂洗脱后电流衰减动力学缓慢。2',3'-O-(2,4,6-三硝基苯基ATP)和异-磷酸吡哆醛-6-偶氮苯基-2'-5'-二磺酸盐是有效的拮抗剂(IC(50)值分别为0.8和22 microM);然而,苏拉明相对无效。逆转录-聚合酶链反应分析证实不存在其他P2X受体亚基。对功能性和非功能性克隆的膜组分进行的蛋白质印迹分析证实细胞膜上存在P2X(6),但显示免疫反应产物的表观分子量存在差异(分别约为70 kDa和约60 kDa)。对功能性和非功能性受体细胞膜进行N-糖苷酶F处理增加了免疫反应产物的电泳迁移率,两种蛋白质均在约55 kDa处迁移,表明与非功能性细胞相比,功能性细胞中P2X(6)受体的糖基化水平增加。本研究表明,无功能的大鼠重组P2X(6)受体1)在人胚肾细胞的膜表面表达,2)被糖基化。新的功能性受体表型的表达与进一步的糖基化相关,导致明显更大的分子量。这些结果表明P2X(6)受体亚基促成了对αβ-亚甲基ATP的敏感性。